Investigators Examine RSV Vaccine Effectiveness Against Hospitalization Among U.S. Adults 60 Years and Older
In June 2023, the Centers for Disease Control and Prevention (CDC) recommended respiratory syncytial virus (RSV) vaccination for adults aged 60 years and older based on high efficacy against RSV…